U.S. Tobacco Stock News

In August 2026, Icahn Enterprises reported second-quarter sales of US$3,081 million and revenue of US$2,975 million, alongside a net loss of US$348 million, and its board declared a US$0.50 quarterly distribution per depositary unit for holders of record on August 17, 2026, payable on or about September 23, 2026. The combination of higher year-on-year sales and revenue with a wider net loss, while maintaining a cash distribution, highlights the tension between Icahn Enterprises’ income...

In early August 2026, Recursion Pharmaceuticals reported Q2 2026 results showing revenue of US$7.67 million versus US$19.22 million a year earlier, with net loss narrowing to US$131.01 million and basic loss per share from continuing operations improving to US$0.25 from US$0.41. While sales and revenue weakened sharply year on year, the smaller net loss suggests Recursion is tightening cost controls even as it pushes forward with its AI-enabled drug discovery model. Against this backdrop of...

Boston Scientific (BSX) is under close watch after a series of voluntary Class II device recalls affecting FARADRIVE steerable sheaths and FARASTAR pulsed field ablation generators used in cardiac and vascular procedures worldwide. See our latest analysis for Boston Scientific. The Boston Scientific share price has climbed in the last month, with a 30 day share price return of 10.14% and a 7 day gain of 5.52%. However, momentum has faded over the past quarter, with a 90 day share price return...

Dividend affirmation and earnings update set the tone for Walker & Dunlop Walker & Dunlop (WD) affirmed a third quarter 2026 dividend of $0.68 per share and released second quarter results, giving investors fresh information on income potential and recent business performance. See our latest analysis for Walker & Dunlop. Those earnings and dividend updates landed after a tough stretch for Walker & Dunlop’s stock, with the share price down 11.55% over 30 days and 24.34% year to date,...

Becton Dickinson stock has delivered a 19.2% return over the past year, and the latest valuation work using a Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares may still trade below that estimate by around 24.4%. At the same time, broad valuation checks point to a more mixed picture and standard earnings multiples look closer to fair value than outright cheap. Becton Dickinson’s 19.2% one year gain puts recent shareholders in profit, which raises the question of how...

First Advantage stock has delivered a 73.8% return over the past three years, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large discount while traditional market multiples lean the other way. First Advantage's 73.8% three year return shows the stock has already rewarded shareholders and raises the bar for any further upside to be justified by fundamentals. Stronger demand for its screening and digital identity services can...

Why Taiwan Semiconductor Manufacturing Stock Is Back in Focus Strong AI related chip demand and expectations for global semiconductor sales to reach about US$1.5t in 2026 have pushed Taiwan Semiconductor Manufacturing (NYSE:TSM) into the spotlight for many investors. The company is being discussed as a key beneficiary of this broad industry demand, with its foundry business positioned across high performance computing, smartphones, automotive and other end markets. See our latest analysis for...

In early August 2026, Willdan Group, Inc. reported second-quarter sales of US$231.03 million and net income of US$24.35 million, both higher than a year earlier, alongside record diluted earnings per share from continuing operations of US$1.58. Alongside these results, Willdan raised its 2026 financial targets, now aiming for full-year net revenue of US$415 million to US$430 million, supported by growing commercial and data center work and recent acquisitions. With record earnings and higher...

Crocs stock has delivered a strong 81.6% return over the past year, yet the latest valuation checks still point to the shares trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and market multiples. The 81.6% gain over the last 12 months suggests sentiment around Crocs has been positive, even with recent swings around company updates. Recent record revenue and changes to how marketplace sales are reported can support cash flow expectations, while a...

Camden Property Trust (CPT) has reshaped its portfolio after completing the sale of its California assets for US$1.625b, redirecting capital toward newer Sunbelt properties, share repurchases, and reaffirmed full year guidance. See our latest analysis for Camden Property Trust. Camden Property Trust's latest California sale and Sunbelt repositioning come after a steady 6.68% 90 day share price return and a 10.40% 1 year total shareholder return. The 5 year total shareholder return shows a...

Intel (INTC) shares are back in focus after the company appointed Dean Jarnac as executive vice president and chief sales officer, putting a new leader in charge of its global sales engine. See our latest analysis for Intel. Intel's recent executive changes and partnerships, including the Terafab joint venture and new foundry customers, come as momentum has cooled in the short term. The 30-day share price return is down 7.46% and the 90-day share price return is down 21.47%, while the...

Lindsay stock reaction and recent performance snapshot Lindsay (LNN) shares recently traded around $116.06, with the stock up about 1.2% over the past day and 4.7% over the past week. Returns over the past month and past 3 months were also positive. See our latest analysis for Lindsay. Short term momentum in Lindsay's share price has picked up recently, with a 7 day share price return of 4.73% and a 90 day share price return of 6.61%. However, longer term total shareholder returns over 1, 3...

Stevanato Group S.p.A. recently reported past second-quarter 2026 results showing sales rising to €302 million from €280.04 million a year earlier, while net income decreased to €22.96 million and full-year 2026 guidance was slightly narrowed alongside confirming expectations for revenue of about €1.26–€1.28 billion and diluted EPS of €0.53–€0.55. A few days earlier, liraglutide-based combination products using Stevanato’s proprietary Alina variable-dose pen injector platform received...

CoreCivic recently completed the sale of four facilities, including two ICE detention centers sold to the U.S. government for an aggregate US$734.0 million, raised full-year 2026 earnings guidance to US$1.50–US$1.52 billion in net income and US$15.00–US$15.20 in diluted EPS, and used part of the proceeds to repay US$608.5 million of debt while expanding its share repurchase authorization to US$1.20 billion. Although these asset sales generate a very large accounting gain in 2026, CoreCivic...

Headlines about DPD and missed sick pay have turned the spotlight on how companies handle worker rights, compliance and payroll. That scrutiny could reshape which businesses clients trust with sensitive employment tasks. For investors, that raises the possibility that some compliance and employment services stocks may stand out. This article explains the story behind that shift and highlights 3 stocks exposed to this news event from our specialist screener. The three stocks in the article...

nVent Electric plc recently reported past second-quarter 2026 results showing sales rising to US$1,471.3 million and net income to US$215.9 million, alongside announcing a new 160,000 square-foot Blaine, Minnesota facility to expand data center liquid cooling capacity. A key insight is that this Blaine expansion marks nVent’s third data center liquid cooling capacity increase in three years, indicating a concentrated push to meet AI-driven infrastructure demand. We’ll now examine how nVent’s...

Bladex earnings and dividend decision set the stage for investors Bladex (BLX) stock is back in focus after the bank reported second quarter 2026 results alongside a new quarterly dividend decision, giving investors fresh numbers on profitability and cash returns. See our latest analysis for Bladex. The latest earnings and dividend news comes after a strong period for Bladex, with the share price up 30.05% year to date and a 1 year total shareholder return of 42.66%. The recent 1 month share...

Intercontinental Exchange (ICE) reported July 2026 operating metrics that show higher trading activity across its markets, with total average daily volume up 25% year on year and open interest up 18%. See our latest analysis for Intercontinental Exchange. The stronger July trading metrics arrive after a busy few weeks for Intercontinental Exchange, which included second quarter earnings, a higher quarterly dividend and ongoing share buybacks. Even with this backdrop, the stock’s recent 30 day...

Abercrombie & Fitch recently marked its Fall 2026 denim campaign with a New York event featuring style figures such as Paloma Elsesser and Emily Ratajkowski, underscoring the brand’s emphasis on fashion identity and urban roots. At the same time, investors are watching the company’s upcoming August 26, 2026 earnings release, with analyst expectations of higher revenue but lower earnings per share and a valuation that screens favorably against industry peers. Next, we will examine how...

Tecnoglass Holdings Inc. has already reported its second-quarter 2026 results, with record revenue of US$295.29 million but lower net income of US$24.56 million and diluted EPS of US$0.55 compared with the prior year, alongside narrowed full-year 2026 revenue guidance of US$1.08 billion to US$1.12 billion. Behind the headline revenue records, the company is contending with higher aluminum costs and Colombian peso strength, which, together with its recent U.S. redomiciliation and shifting...

Kodiak Sciences has completed enrollment of the first 300-patient cohort in its Phase 3 PEAK trial of KSI-101 for macular edema secondary to inflammation, advancing a bispecific IL-6/VEGF therapy through a pivotal analysis that will inform regulatory paths. An interesting aspect of this update is how PEAK and the complementary PINNACLE study are structured to span a broad spectrum of MESI severity, from mild to more advanced disease, potentially broadening the therapy’s clinical relevance if...

In early August 2026, Tarsus Pharmaceuticals reported second-quarter revenue of US$173.91 million and a net loss of US$18.55 million, while also raising full-year 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. The earnings update highlighted strong XDEMVY uptake, with more than 700,000 patients treated since launch and an acquisition of Alkeus Pharmaceuticals to broaden Tarsus’ ophthalmology pipeline. We’ll now examine how this stronger XDEMVY sales outlook and...

Why Toast stock is back in focus Toast (TOST) is drawing fresh attention after announcing an expanded integration with Google for AI powered food ordering in Google Maps, alongside a new endorsement as a point of sale option by BWH Hotels. See our latest analysis for Toast. For context, Toast’s share price is US$34.48, with a 30 day share price return of 17.6% and a 90 day share price return of 42.54%, while the 1 year total shareholder return is down 19.96% and the 3 year total shareholder...

Solaris Energy Infrastructure, Inc. recently reported past second-quarter 2026 results showing sales of US$105.72 million and net income of US$20.49 million, alongside affirming a third-quarter dividend of US$0.12 per share, marking its 32nd consecutive payout. Despite year-on-year growth in revenue and net income for both the quarter and first half of 2026, diluted earnings per share from continuing operations eased slightly in the latest quarter, hinting at increased share count or mix...